SCHEMBL6206842

SCHEMBL6206842

CCc1ccc(Nc2c(-c3nnc(N(CC)CCN(C)C)o3)ccc(F)c2F)c(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206400 0.85
SCHEMBL6399021 0.83 CRHR1 (0.33)
SCHEMBL6207240 0.82
SCHEMBL6400380 0.82 FLT1 (0.32)
SCHEMBL6207753 0.81 MAP2K2 (0.34)
SCHEMBL6400419 0.79 KDM4E (0.38)
SCHEMBL6189167 0.78 MAP2K1 (0.42)
SCHEMBL6207023 0.77 HTR2A (0.31)
SCHEMBL6399255 0.77 CNR2 (0.31)
SCHEMBL6399685 0.77 ELANE (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578736-A1 MEK INHIBITING OXA- AND THIA-DIAZOL-2-YL-PHENYLAMINE DERIVATIVES Warner-Lambert Company LLC (US) 2005-09-28 EP claimed
US-20050004186-A1 MEK inhibiting compounds PFIZER INC 2005-01-06 US claimed
WO-2004056789-A1 MEK INHIBITING OXA- AND THIA-DIAZOL-2-YL PHENYLAMINE DERIVATES WARNER-LAMBERT COMPANY LLC (US) 2004-07-08 WO claimed
US-20050004186-A1 MEK inhibiting compounds PFIZER INC 2005-01-06 US disclosed